Fig. 1. Patient selection. Two hundred forty-one patients with newly diagnosed ovarian cancer were seen between 7/1/2015 and 12/1/2017 and recommended to receive NACT. Of these, 224 were included in this analysis.
NACT, neoadjuvant chemotherapy.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.